Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Cash (2016 - 2025)

Mesa Laboratories' Change in Cash history spans 16 years, with the latest figure at $8.6 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 29.22% year-over-year to $8.6 million; the TTM value through Dec 2025 reached -$2.0 million, down 172.51%, while the annual FY2025 figure was -$893000.0, 80.98% up from the prior year.
  • Change in Cash for Q4 2025 was $8.6 million at Mesa Laboratories, up from -$857000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $11.8 million in Q2 2021 and bottomed at -$226.6 million in Q4 2021.
  • The 5-year median for Change in Cash is -$695500.0 (2023), against an average of -$11.2 million.
  • The largest annual shift saw Change in Cash soared 388.52% in 2023 before it crashed 36250.0% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$226.6 million in 2021, then surged by 97.23% to -$6.3 million in 2022, then dropped by 17.8% to -$7.4 million in 2023, then skyrocketed by 189.53% to $6.6 million in 2024, then increased by 29.22% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Change in Cash are $8.6 million (Q4 2025), -$857000.0 (Q3 2025), and -$6.0 million (Q2 2025).